Novolog and Gallbladder disorder - a phase IV clinical study of FDA data

Summary:

Gallbladder disorder is reported as a side effect among people who take Novolog (insulin aspart recombinant), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Lantus, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Gallbladder disorder when taking Novolog. It is created by eHealthMe based on reports of 55,653 people who have side effects when taking Novolog from the FDA, and is updated regularly.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.

What is Gallbladder disorder?

Gallbladder disorder is found to be associated with 1,191 drugs and 1,786 conditions by eHealthMe. Check the latest studies of Gallbladder disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

55,653 people reported to have side effects when taking Novolog.
Among them, 99 people (0.18%) have Gallbladder disorder.

Could Novolog cause Gallbladder disorder?

Among these 99 people:

How long have people been on Novolog when they have Gallbladder disorder? *

What is the gender of people who have Gallbladder disorder when taking Novolog? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Gallbladder disorder when taking Novolog? *

What are other drugs people take besides Novolog? *

What are other side effects people have besides Gallbladder disorder? *

Nausea (feeling of having an urge to vomit): 23 people, 23.23%
Nausea And Vomiting: 21 people, 21.21%
Dyspnea (difficult or laboured breathing): 21 people, 21.21%
Gallstones (stone formation by bile component): 17 people, 17.17%
Abdominal Pain: 16 people, 16.16%
Weakness: 15 people, 15.15%
Blood Glucose Increased: 14 people, 14.14%
Constipation: 14 people, 14.14%
Fatigue (feeling of tiredness): 14 people, 14.14%
High Blood Pressure: 14 people, 14.14%

What are the existing conditions these people have? *

High Blood Cholesterol: 14 people, 14.14%
High Blood Pressure: 13 people, 13.13%
Birth Control: 7 people, 7.07%
Dyslipidaemia (abnormal amount of lipids): 6 people, 6.06%
Itching: 5 people, 5.05%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 5.05%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 5.05%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.04%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 4.04%
Cardiac Failure Congestive: 4 people, 4.04%

* Approximation only. Some reports may have incomplete information.

Do you take Novolog and have Gallbladder disorder?

- Check whether Gallbladder disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolog:

Novolog (56,160 reports)

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gallbladder disorder:

Gallbladder disorder (1,191 drugs)

Browse all the conditions that are associated with Gallbladder disorder:

Gallbladder disorder (1,786 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novolog) and Novolog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.